Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 203985

Expand all

AFINITOR DISPERZ (EVEROLIMUS)
2MG Marketing Status: Prescription

Active Ingredient: EVEROLIMUS
Proprietary Name: AFINITOR DISPERZ
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 2MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N203985
Product Number: 001
Approval Date: Aug 29, 2012
Applicant Holder Full Name: NOVARTIS PHARMACEUTICAL CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

AFINITOR DISPERZ (EVEROLIMUS)
3MG Marketing Status: Prescription

Active Ingredient: EVEROLIMUS
Proprietary Name: AFINITOR DISPERZ
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 3MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N203985
Product Number: 002
Approval Date: Aug 29, 2012
Applicant Holder Full Name: NOVARTIS PHARMACEUTICAL CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

AFINITOR DISPERZ (EVEROLIMUS)
5MG Marketing Status: Prescription

Active Ingredient: EVEROLIMUS
Proprietary Name: AFINITOR DISPERZ
Dosage Form; Route of Administration: TABLET, FOR SUSPENSION; ORAL
Strength: 5MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N203985
Product Number: 003
Approval Date: Aug 29, 2012
Applicant Holder Full Name: NOVARTIS PHARMACEUTICAL CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English